DatasetName,MTFR1L_S(107) MTFR1L_S(110) MTFR1L_S(13) MTFR1L_S(141) MTFR1L_S(167) MTFR1L_S(211) MTFR1L_S(222) MTFR1L_S(223) MTFR1L_S(224) MTFR1L_S(225) MTFR1L_S(226) MTFR1L_S(232) MTFR1L_S(234) MTFR1L_S(237) MTFR1L_S(242) MTFR1L_S(243) MTFR1L_S(261) MTFR1L_S(41) MTFR1L_T(44),MTFR1L_S(100) MTFR1L_S(103) MTFR1L_S(238) MTFR1L_S(3) MTFR1L_S(6)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.5200900672379737,0.6912894592617387
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.6686346189475193
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.6814183995660781
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.7038013334646133
HS2024_6_B_T3,,
JW2015_Intensity pre1,0.5046880757133618,0.622882236646635
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.625449980004683
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5001602265104927,0.6401551111064341
DB2022_Intensity L2,,0.6262334471430095
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5050356122289085,0.6481457582818505
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.49847067269842615,0.62937575350471
WZ2023_Pu_010_30min,0.5082282765771289,0.6845727174051863
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.6942915329552769
RB2022_8_RecoveryEndurance,0.5000886517204283,0.5989819369177332
KBE2022_Log2_Ex_14_U,,0.6507366393241745
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.6896474083203035
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.609286975100094
RB2022_5_PreSprint,0.49957669541770894,
PG2020_Intensity 8h_C,,0.6341051652582855
AH2018_SILAC_MR_2_N,,0.7042394887649249
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.6613519272383278
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.48391157020756165,0.5797848034226848
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.6594060953897513
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5118123476195668,0.6474512597962263
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.4939540245376365,0.6167292654926666
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.6624997312767904
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.6842715767779136
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5044436703415376,0.6852453962398736
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.5050086912633133,0.647775336371524
KBE2022_Log2_Ex_34_U,0.5016107095995811,0.643680528943978
WZ2023_Pu_005_10min,0.508081694347055,0.6858992063374227
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.645710706431881
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5040073023336085,0.6823907816476932
AH2018_SILAC_MR_2_X,,0.6518213933051447
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4908827789123153,0.6018158750389443
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5148861243443832,0.6702583446327244
EJN2021_3_Rest_Basal,0.49770434377399025,0.6692268864836249
CR2017_Ratio Replicate 1.3,0.49802052216850445,0.5966539834023523
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.6707200378725083
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.6713999586905102
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,0.6504822704698865
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.503439740705996,0.635283326730733
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5068705019731552,0.6829295777467483
CK2022_11 40-1,,0.6453308910437305
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.661346073436518
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5000885151393827,0.6206570127792419
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.5047730536721781,0.6874667901969194
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.48921052606015153,0.6292255944226096
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.6549499378066583
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,0.6145319002919368
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.6489339830307027
CK2022_1 200-1,0.5013375027208324,0.6110176184769267
PG2020_Intensity Mock_10h_D,,0.6214083518253284
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.493401206306716,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5164177016252092,0.6253587483369613
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.526024339583803,0.663233683411795
PG2020_Intensity 2h_C,,0.6223105992843377
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.7028142583575949
KBE2022_Log2_Ex_8_T,,0.6527187486568229
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.6793828913313861
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.6569616358417485
CK2022_3 40-1,,0.6598524905493828
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5035162079407454,0.6572527303412979
HH2022_Reporter intensity 8,,
ZQ2022_N2,,0.6696656286908842
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.705872991480951
EJN2021_5_Rest_Basal,0.49767199545739094,0.6679549768224871
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.6696654872989602
YA2020_Reporter_intensity_Normal_No.1,0.5062029385176313,0.6838763089164327
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.5043889600111752,0.6083205094212408
RB2022_1_PostEndurance,0.517679155988872,
CR2017_Ratio Replicate 3,0.5260993203723184,0.6042324895209564
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.5055107496168215,0.6327048457339173
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.6784196010656607
HS2024_8_I_T3,,
CF2017_EOC 3,0.5072094661891939,0.6605827323436129
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.5058001831190727,0.64462682705926
WZ2023_Pu_010_20min,0.5118619596356325,0.6853313889451286
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.6586001181184843
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.6450337396520901
CK2022_8 16-1,,0.6662786306574902
KS2014_Intensity N3,0.4927450687086184,0.5966657909084647
RB2022_4_RecoveryEndurance,0.5027628415073527,0.6233285221030157
RB2022_5_RecoveryEndurance,0.5012316737711068,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.683164726171906
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.6443982823136812
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5089395609753431,0.6622765297101256
KS2014_Intensity E15_2,0.4959295803554596,0.623209033997111
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.6595994225586994
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.6731404133738984
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5010455794292493,0.6309049552901842
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.6959887182870291
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.519991433339261,0.6787672264250955
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.6487265325183079
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4997502964233224,0.6312821930757476
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.6555794297926102
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.645894186303041
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.6509846607838073
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.6190200227172094
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.6514823772145969
RB2022_6_PreSprint,0.5004789275194877,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5863504382909148
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.6795021068992231
DL2023_control-1,,
AR2021_ALG 10 μM,0.5001509047773612,0.620839434504604
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.6799027212351237
EJN2021_4_Rest_Ins,0.49379318922926924,0.667195329983902
RN2012_H05,0.5056411379136719,0.6283564832736592
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.6101066995729967
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.5164288249404484,0.6614026154606244
EJN2021_1_Rest_Ins,0.49821241575105285,0.666652236267532
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.6861379083503434
JW2021_After_3,0.49854488090935023,
GF2025_P8_Sph,,0.6218455474743487
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.6560829984416057
CK2022_11 200-1,0.5037104992507352,0.6106856746756654
CK2022_12 200-1,0.5038061571776375,0.61026339895128
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5026820673056012,0.6897521002483317
AH2018_TMTMS2_2_N,,0.6893808999306779
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5026499070892372,0.64375363677768
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.6376041167410258
AH2018_TMTMS3_Pool,,0.7101955129758003
KS2014_Intensity N4,0.5016715621357303,0.5939858838131206
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.6312337170374053
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5102521335890984,0.6575293170233405
CK2022_14 200-1,0.5064609724571949,0.6327563841154461
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5114360520358263,0.6523185056383388
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.7160250863176794
AST2020_anti-CD3+PDL2.2,0.5051997877985767,0.6496490321846126
PG2020_Intensity Mock_10h_A,,0.6392961683639605
JW2021_After_2,0.49747237712337194,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.49656367801837314,0.6651097195600533
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.6471974187638102
GF2025_P1_Adh,,0.5731029589161416
GF2025_P1_Sph,,0.6529099499996722
EJN2021_5_Ex_Basal,0.5013580071138266,0.674638999663853
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5116535230415933,0.6756761691680306
CF2017_EOC 1,0.5073038337391944,0.6651544038578898
CK2022_3 200-1,0.5011171717566008,0.6097947327924603
AH2018_LFQ_IT_3_C,,0.655533672097968
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.6586621113932122
RB2022_1_PostSprint,0.5112716533285832,
CK2022_4 200-1,0.5006240572759417,0.6101598946455008
JW2021_Before_2,0.5123912095441546,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.670337393904658
AR2021_ALG 1 μM,0.5033585575024458,0.6313186092518326
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.4987859380477498,0.665548732610603
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5271989567752321,0.6733878470214574
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5852778005482744
CK2022_9 16-1,,0.6369619295026183
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5063630855509602,0.6314800022674144
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.6365291826895
CK2022_16 16-1,,0.6461345869500575
FS2019_db/db3,0.505356719166989,0.6426011775666762
CK2022_15 40-1,,0.6508124265455904
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5008290840255207,0.6840520770449399
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5030344597845825,0.6448920160725362
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.661247215586511
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.7004389432772952
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.6534467935989989
AH2018_LFQ_M_1_N,,0.6981066130301528
KBE2022_Log2_Ex_27_U,,0.6548537779253117
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.6834212926125172
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.4923041470814981,0.6021737387074771
YA2020_Reporter_intensity_Normal_No.4,0.5034144623994569,0.6836208062619329
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.6287487490587889
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.6382644916579453
RN2012_L13,0.5039389481626827,0.6240490277792407
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.6542220572367186
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.6470055314921954
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5217999965329602,0.6755028910321077
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.487496005073756,0.6210634127743037
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.6950013063810376
GF2025_P3_Adh,,0.6218980913309538
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.6964084040685521
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5042984649070402,0.5993738835573856
KBE2022_Log2_Ex_19_U,,0.6606399706526453
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.5114137180173346,0.6484248822512768
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.6415570072796597
AST2020_Control,0.5048141898934994,0.6500486987424725
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.6592405203153648
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.4957489296837203,
RB2022_7_RecoverySprint,,0.6185994435992097
YA2020_Reporter_intensity_Normal_No.3,0.503536080070578,0.6767597789192108
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.6861775320942222
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5023857202920687,0.600619833524413
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5034056772611578,0.6689134780619411
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.6466362032243348
EP2017_Untreated R#2 log2 ratio,0.5043697202185883,0.6636282160936393
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4752720979596211,0.6293668406471536
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.49957668034468145,0.6069338022200608
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.6595786513696431
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.7027782006838457
KBE2022_Log2_Ex_9_U,,0.6544026755717065
AH2018_SILAC_M_3_N,,0.6713804206767932
KBE2022_Log2_Ex_13_T,,0.6558240061306113
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5904441337282481
CF2017_OSE 29,0.509653178658137,0.6541477495481948
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.6078913351253051
RN2012_L12,,0.6742373239431674
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.6676876459067806
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,0.5024556645048099,0.6217839563581123
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.6672336862256598
RB2022_7_RecoveryEndurance,0.500251127318154,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5030207560694672,0.6731853840461894
TM2022_S2.12h.B,,
RN2012_L15,0.5079982435780729,0.6404876789235077
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5834654034127621
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5006170442851602,0.636393563501956
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5060213773966648,0.6122418293362949
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5025564463035161,0.6374592918915207
CK2022_5 200-1,0.5026822788109743,0.6374607345144758
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.5168955916493472,
AH2018_LFQ_2_C,,0.6467710825394557
AH2018_SILAC_MR_1_X,,0.6897884203453755
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5033522496386137,0.6438915038591684
AH2018_SILAC_3_C,,0.6677077897288832
EJN2021_5_Rest_Ins,0.4954375153971817,0.6685956096694412
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.6366955133412904
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,0.6502302380892541
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.4992233770892388,0.666328165484017
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.6915822678914557
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,0.6543420353224041
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.664981925528053
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.49931956586357407,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.6585505942864534
AH2018_SILAC_IT_2_N,,0.6807939975285462
AH2018_SILAC_IT_1_X,,0.6506776822495556
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.6591002613580728
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.6604911898499608
WZ2023_Pe_025_20min,0.5037343199158254,0.6818607104159489
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.6749297703185848
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.6948855261642561
RN2012_H06,0.5032064728501666,0.6522793288463579
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5008810675035948,0.6814715473250363
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.6582924709602183
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5347895051051328,0.6562632457471024
WZ2023_Su_025_10min,0.5112359225155987,0.6879654555846874
AH2018_LFQ_IT_4_X,,0.6707170653475372
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5017438076118982,0.686325544435956
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5005292290368833,0.6514117887768166
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5046023339119049,0.6466091953818591
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.6341185077856324
LY2019_P7+,0.48538321945226887,0.6231278317409237
EP2017_Untreated R#1 normalized log2 ratio,0.49717453686370044,0.6402099076201365
RN2012_L10,0.4996479091368318,0.6445976734868721
PG2020_Intensity 4h_C,,0.6411961888194415
EP2017_Mitotic R#3 normalized log2 ratio,0.5160948707626091,0.6239466483580178
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,0.6067974946175969
KBE2022_Log2_Ex_24_T,0.5009329141990515,0.6362329540045053
RB2022_8_PostStrength,0.5099653557240845,0.632995899039914
AH2018_SILAC_IT_2_X,,0.6556005782877969
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5001121913726336,0.6395580222443247
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5042834078377745,0.6517883295698044
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5063533529829456,0.6322559056030276
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5178044778666362,0.6321202267460457
GF2025_P9_Sph,,0.6778080705793548
CK2022_6 200-1,0.5026180965137672,0.6367700618964333
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.6903460309766554
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,0.502951468438383,0.6170767105714011
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.6325373341298342
PG2020_Intensity 2h_D,,0.617848157778519
EP2017_Untreated R#3 normalized log2 ratio,0.5143978588400984,0.6213806769132588
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5025041707026938,0.6359782267487619
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5260722229054512,0.6215819717353177
RB2022_7_PostEndurance,0.5156570283261955,0.6573842435591364
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5052943003576091,0.6543155172897869
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.6556035025494229
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.6581259538935389
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5030784654702886,0.6712555637923691
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.5138183547851699,
AH2018_SILAC_MR_3_N,,0.6574370175890273
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5080839592018341,0.6694469940396377
PG2020_Intensity CT_C,,0.5997768172225963
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,0.6780085817870317
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.501419102663339,0.6360602726214707
EP2017_Untreated R#3 log2 ratio,0.5163882878482838,0.6241028959178504
RB2022_2_PostStrength,0.5113850871120021,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5450620954932086,0.6103935966642183
HS2024_8_PD_T2,,
FS2019_Ctr2,0.5046963681025931,0.6362846486074059
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5023999831021683,0.6460195678017749
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5194468354589292,0.6507339971650703
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5991606222903936
YA2020_Reporter_intensity_Normal_No.2,0.5049954576233258,0.6961433034342233
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.6833955720872706
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.655252105169522
CK2022_2 16-1,,0.6499510131127066
RAM2015_Log2 B,,0.6540657622478263
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.4964084270778417,0.6655325400021574
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.6560702932118028
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,0.5007901556648064,0.6115866564677238
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.6520926128440101
WZ2023_Su_025_30min,0.5019534387586637,0.6894976701251243
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,0.500000933394513,0.6333772361620631
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.684608528305434
RB2022_7_PreEndurance,0.5057563528732241,0.6344627226398163
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5267784943772346,0.6531237826679108
DB2022_LFQ intensity R2,,0.6158983491674918
GF2025_P6_Adh,,0.5731432870360289
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.5210791672981715,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.7160742495871917
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5071615654830453,0.6104481927949708
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.5056541305445225,0.6330171264322864
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.6282432076640672
GF2025_P9_Adh,,0.5819063279020014
RB2022_3_PostStrength,0.5155648427563048,0.6671028807974325
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.6834171078816962
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.6443449085675004
AH2018_LFQ_2_X,,0.6639474377770298
PG2020_Intensity 2h_B,,0.6023027076617622
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.513068080805377,0.6543736992238698
KS2014_Intensity E15_3,0.4946582030369476,0.6134908475951204
GF2025_P3_Sph,,0.667853130516743
DB2022_LFQ intensity L2,,0.6175443602566438
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.681397432316558
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.6516185565197137
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.6781317275502659
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.4979894362240036,0.6201728157531224
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.48114211955681907,0.6733365431750009
ZQ2022_N1,,0.6621020810085785
LY2019_P6-,0.5257825942523392,0.6572776387410219
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.6576141100071227
JW2015_Intensity pre2,0.5023689973743353,0.6119498187110588
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5049914340462897,0.661738734093982
AH2018_LFQ_3_N,,0.6746681602484675
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5020184911213761,0.5972064197006668
UK2020_UA_1,,0.6558118650506133
KBE2022_Log2_Ex_13_U,,0.6554904646084394
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.6454383868453504
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.6671356424384411
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5792834272449804
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,0.6209057869436811
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.5216477189143972,0.6846952593620763
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5044830545468659,0.6891617881898062
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5080664811885421,0.6252171321792654
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.6523628512318618
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5098469236492625,0.648991032325831
PG2020_Intensity 10h_D,,0.6149067318848326
RB2022_8_PreEndurance,,0.6067475929799416
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.4991109282919283,0.6683902711005685
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5014087794678661,0.6680502926325056
EP2017_Pervanadate R#3 log2 ratio,0.5120284247425196,0.6477785582996713
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.6960263049592003
AH2018_LFQ_M_4_C,,0.6832581381172405
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,0.6081398764110826
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.503515102647403,0.6448599283429515
CK2022_6 40-1,,0.6675514880678055
DB2022_LFQ intensity R2.1,,0.6190168948982522
KBE2022_Log2_Ex_42_U,0.5008294691333705,0.6486997851545888
LY2019_P3-,0.5293187155895792,0.6837482406474462
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5010542324550231,0.6713092097495144
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5055073188679344,0.6802933133662167
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5027074664895768,0.6746150957839949
AST2020_Control.1,0.504962881816859,0.6491459539685461
JW2015_Intensity cap1,0.5045888613940607,0.6025328206507699
PG2020_Intensity CT_A,,0.6304749433042214
FS2019_Ctr3,0.5057342419276233,0.6422873241713101
WZ2023_Pu_025_20min,0.505453080178431,0.6842592439708872
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.6606339048464458
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.6874684178224956
RB2022_4_PreSprint,0.49953971006159664,0.5954058922797696
DB2022_Intensity R2,,0.6271600433752519
AH2018_TMTMS2_Pool,,0.7181554037668265
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.6826025942100973
LY2019_P8+,0.5084284078244026,0.6473806936584252
RB2022_2_RecoveryEndurance,0.506221728120218,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.5149550572476012,0.6682726841194399
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.6463792359663261
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.7039592538911068
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5032581691303245,0.632864411894816
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5121343010295124,0.6823413508020785
LY2019_P2-,0.5294914852165736,0.7053521041232234
AH2018_LFQ_IT_1_X,,0.6856819401566647
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5030124610761842,0.6797583972087881
AST2020_Control.2,0.504928209888352,0.6501818799121764
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.6587123212470948
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5093377526053889,0.6738747290062156
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.6533700675368077
AH2018_TMTMS3_3_N,,0.712728395962502
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.682398337320181
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5074858461772438,0.614135384537194
KBE2022_Log2_Ex_36_T,,0.6590130126956534
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.49975717463701175,0.6885147950395331
KS2014_Intensity C2,0.5040020406906361,0.6093309292106078
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5022418003806604,0.636331878583776
CK2022_9 200-1,0.5028942046816687,0.608556404197014
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5029818145774001,0.6083381375745692
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.4819972503893374,0.5777219488864604
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.51249374834011,0.665301104486846
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5074433782518629,0.5985913303714401
ZQ2022_C3,,0.6075679869383039
EJN2021_3_Rest_Ins,0.4986605679969481,0.6689752430691634
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5027098846999098,0.6356199539133617
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4983253022039927,0.6428507956664435
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5095552913507234,0.6851106633809559
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5042572977001774,0.5883593195816437
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4996158029364781,0.6584204074426051
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.6914826580810267
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.6232541169877723
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.6819287377582472
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.6703690994567936
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.49807207687695004,0.6055695081184964
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5051083820508504,0.6499679103995167
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5032293271133502,0.6812636029979692
KBE2022_Log2_Ex_29_U,,0.6537642106066139
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.6735462137919765
AH2018_LFQ_IT_4_N,,0.6696849683904754
CK2022_15 200-1,0.5060723265177737,0.6301871129560419
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5026046339411883,0.6450876398349032
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.502199318708044,0.6644461217848192
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.501165263357249,0.6095452064483973
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5022654390819843,0.6876056480155078
RN2012_H01,0.5038660087831429,0.6548395882582406
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.49768144338842385,0.6674806736836671
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.6660489998335132
EP2017_Pervanadate R#1 normalized log2 ratio,0.5003049817261097,0.6511783914229887
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5037240548810588,0.669787336338666
KBE2022_Log2_Ex_44_U,0.4995595145389938,0.6386815906095102
WZ2023_Pe_010_20min,0.5018487034103996,0.6838681835612925
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.49889572370053475,0.6181886316995192
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.6552423337664809
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5016174132632871,0.6683126456036473
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,0.6705952350360619
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.6689895636734067
AH2018_SILAC_M_2_X,,0.6701024408561942
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5020568783327173,0.6475767421176306
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.500947070814617,0.6879940943198504
PG2020_Intensity 6h_C,,0.6580182270304105
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.6829646401254215
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.6943363106693755
CK2022_15 16-1,,0.6488481943133065
CK2022_3 16-1,,0.6496327590654013
LY2019_P4-,0.48180534727793334,0.5381564232033139
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5941641795702746
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.6939768445341634
CK2022_10 16-1,,0.6354399083240928
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.660768077428011
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,0.6234777312637017
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.6589506969523212
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5069282275474781,0.6205834459855477
EJN2021_2_Ex_Basal,0.4987906702444312,0.6696405878320479
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5089435001207354,0.6786854861489402
AR2021_L41 10 μM,0.5089790975865247,0.6559007022685664
CF2017_EOC 2,0.5078120332239722,0.6709398101020383
RB2022_6_PostEndurance,0.5184998430570165,
AH2018_SILAC_1_N,,0.683142393350324
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.658269662704759
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.6676920933760416
ZX2022_CB treated Replicate 1,,0.6931492045514475
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.6869546291807962
AR2021_L41 1 μM,0.5101353347377967,0.6628447952930764
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.6981889631482004
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.7014750838794935
KS2014_Intensity C4,0.5059761467318923,0.6307626028448334
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.659422901726941
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.6904163572973491
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5022187330851857,0.653562177140204
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.6854070162206968
WZ2023_Pu_025_10min,0.5121080347476716,0.6851636177260406
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.508503767858935,0.678881081890321
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5041962479234131,0.6847541602318851
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.6560734294523863
KS2014_Intensity C6,0.5041231710427175,0.6180728303388195
ZQ2022_N3,,0.6803106811374429
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.6456853515900173
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.7037790068080986
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.6504296267957763
AH2018_SILAC_IT_2_C,,0.6880037087903151
CK2022_5 40-1,,0.6690717333324219
AH2018_LFQ_3_X,,0.6540717673829277
UK2020_UA_3,,0.659533480950089
LY2019_P7-,0.5054406646814505,0.6441116792278752
GF2025_P5_Adh,,0.5739989259760688
RB2022_1_PostStrength,0.5069229863055259,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.4958633642176585,0.6328281013467698
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.6431015374629906
CK2022_11 16-1,,0.6372035015364954
ZQ2022_C1,,0.6205016369843064
CR2017_Ratio Replicate 2.1,0.5144834531566179,0.6281929470547358
PG2020_Intensity CT_B,,0.6451505296678351
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.6796639184533108
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,0.512900439150319,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.6559085135744857
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.5034759864443105,0.667097149270306
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.6818783441325384
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.6587094593232947
YA2020_Reporter_intensity_Cancer_No.4,0.5021282156143995,0.6586797051704585
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.6428520003697276
RB2022_2_PreEndurance,,
JW2021_Before_1,0.5178368873697198,
KBE2022_Log2_Ex_25_T,0.5038064928832223,0.6427212507733117
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.6480691472030038
AST2020_anti-CD3+PDL2,0.5050438430765825,0.649230332995597
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.6556102299198346
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.5082422477952565,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.6537030220785358
EP2017_Mitotic R#2 log2 ratio,0.506303249518346,0.6139865304962127
AH2018_TMTMS2_1_X,,0.6981640170365302
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5004236815200389,0.6694756790142284
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5092207954933986,0.6783054574937697
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.6855003264965376
PG2020_Intensity 10h_B,,0.601153966536508
AH2018_TMTMS3_1_X,,0.7228165634242044
CF2017_FTE 14,0.5097957363852857,0.6697256163733247
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.6509418990727429
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.6494925676816268
EP2017_Untreated R#2 normalized log2 ratio,0.5033014308722725,0.660805653456449
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,0.6101210441900399
LY2019_P5+,0.49469565202145327,0.5915852628392553
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5055755212669799,0.6546778792832142
AS2011_Ratio H/L Normalized RNAi_2_1,,
